Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lethagen

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Lakartidningen|August 24, 1994
[Ambulatory treatment without complications. A 1-year experience in distal deep-vein thrombosis]P Svensson, S Lethagen, E Lindén, et al.
Blut|March 1, 1990
Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type IS Lethagen, A S Harris, I M Nilsson
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
The administration of desmopressin by nasal spray: a dose-determination study in patients with mild haemophilia A or von Willebrand's diseaseS Lethagen, K Egervall, E Berntorp, et al.
Acta Orthopaedica Scandinavica|August 5, 2000
Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplastyG Benoni, S Lethagen, P Nilsson, et al.
Acta Chirurgica Scandinavica|September 1, 1990
Effects of desmopressin acetate (DDAVP) and dextran on hemostatic and thromboprophylactic mechanismsS Lethagen, P Rugarn, M Aberg, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2005
Genetic analysis of 31 Swedish type 1 von Willebrand disease families reveals incomplete linkage to the von Willebrand factor gene and a high frequency of a certain disease haplotypeE Lanke, A M Johansson, C Halldén, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 21, 2000
The Malmö model for immune tolerance induction: impact of previous treatment on outcomeE Carlborg, J Astermark, S Lethagen, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 13, 2000
NovoSeven in warfarin-treated patientsE Berntorp, L Stigendal, S Lethagen, et al.
Thrombosis and Haemostasis|January 10, 1998
von Willebrand factor mediates increased platelet retention in recurrent thrombotic thrombocytopenic purpuraD Karpman, S Lethagen, A Kristoffersson, et al.
Lakartidningen|October 6, 2001
[New in vitro analysis tested: bleeding time is still the best method for evaluation of primary hemostasis]P Ridefelt, N Egberg, A Hillarp, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Lakartidningen|August 24, 1994
[Ambulatory treatment without complications. A 1-year experience in distal deep-vein thrombosis]P Svensson, S Lethagen, E Lindén, et al.
Blut|March 1, 1990
Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type IS Lethagen, A S Harris, I M Nilsson
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
The administration of desmopressin by nasal spray: a dose-determination study in patients with mild haemophilia A or von Willebrand's diseaseS Lethagen, K Egervall, E Berntorp, et al.
Acta Orthopaedica Scandinavica|August 5, 2000
Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplastyG Benoni, S Lethagen, P Nilsson, et al.
Acta Chirurgica Scandinavica|September 1, 1990
Effects of desmopressin acetate (DDAVP) and dextran on hemostatic and thromboprophylactic mechanismsS Lethagen, P Rugarn, M Aberg, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2005
Genetic analysis of 31 Swedish type 1 von Willebrand disease families reveals incomplete linkage to the von Willebrand factor gene and a high frequency of a certain disease haplotypeE Lanke, A M Johansson, C Halldén, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 21, 2000
The Malmö model for immune tolerance induction: impact of previous treatment on outcomeE Carlborg, J Astermark, S Lethagen, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 13, 2000
NovoSeven in warfarin-treated patientsE Berntorp, L Stigendal, S Lethagen, et al.
Thrombosis and Haemostasis|January 10, 1998
von Willebrand factor mediates increased platelet retention in recurrent thrombotic thrombocytopenic purpuraD Karpman, S Lethagen, A Kristoffersson, et al.
Lakartidningen|October 6, 2001
[New in vitro analysis tested: bleeding time is still the best method for evaluation of primary hemostasis]P Ridefelt, N Egberg, A Hillarp, et al.
Pageof 10